Pistoia Alliance announces 2019 Life Science Industry trends

Members of the Pistoia Alliance and Clarivate Analytics have collaborated on producing a report citing key trends for the life science industry in 2019. Its key findings include:
Innovation is being driven via collaboration from multiple industry stakeholders
Technologies are being adopted to advance drug research
New types of research are coming to the forefront
Digitization of R&D and healthcare will increase
Academia is increasingly contributing to biologics R&D

Clarivate Analytics’ global head of life sciences professional services & consulting and co-author of the report, Christopher McKenna, said: “The life sciences industry is at a real crossroads heightened global competition, tougher regulatory standards, and continued cost pressures make efficient innovation in R&D more imperative than ever. I’m encouraged by what our analysis reveals. Cross-stakeholder collaboration, new digital technologies and therapeutic approaches, and the role of cloud-based computing, among others, are having a dramatic impact on drug and device development. This will continue to expand in 2019 and beyond, enabling more novel therapies to reach the market with the advancement of more permanent efficacy for patients.”
President of The Pistoia Alliance, Steve Arlington, said: “One of the aims of The Pistoia Alliance has always been to support life science companies, and one way we do this is by helping organisations set their R&D priorities and plan their investments. Members of The Pistoia Alliance benefit from exclusive access to information from us and our partners – the Clarivate Analytics report is a good example of this. Given the Alliance’s primary goal of increasing collaboration within the life science industry and with other sectors, we are not surprised to see the link between the key trends for next year is the need for co-operation and input from a range of disciplines. We will continue to support our members to accelerate R&D innovation in 2019, and to help make progress on improving the lives of patients around the world.”